Skip to content
Boston Health Longevity

Stem Cell Therapy for Chronic Joint Degeneration in Thailand

Slowing degeneration and supporting joint preservation across multiple joints

Apply for Assessment No-obligation consultation
Clinician-Led
International Patients
Competitive Pricing
Testimonials →

Understanding Chronic Joint Degeneration

Chronic joint degeneration encompasses the progressive deterioration of joint structures, cartilage, bone, synovium, and supporting tissues, that occurs with ageing, wear, previous injury, or systemic conditions. Unlike single-joint osteoarthritis, many patients experience multi-joint degeneration affecting their knees, hips, shoulders, hands, and spine simultaneously. This polyarticular involvement significantly impacts quality of life and functional independence. Mesenchymal stem cell therapy offers a systemic regenerative approach that may address the underlying degenerative processes across multiple joints, delivering anti-inflammatory and regenerative benefits. Treatment is delivered at Boston Health Longevity in Chiang Mai with comprehensive multi-joint assessment and tailored protocols.

Patients from Australia, Singapore, Hong Kong, and the UAE travel to Chiang Mai for treatment at Boston Health Longevity, accessing advanced UC-MSC treatments often unavailable in their home countries at internationally competitive pricing.

What Causes Chronic Joint Degeneration?

Age-related decline in the regenerative capacity of joint tissues is the primary driver. As we age, chondrocytes (cartilage cells) become less active, proteoglycan content decreases, and the cartilage becomes thinner, less resilient, and more vulnerable to wear.

Cumulative mechanical wear from decades of use, particularly in weight-bearing joints. The knees, hips, and spine bear the greatest loads and are typically the first to show degenerative changes.

Previous injuries across multiple joints create sites of accelerated degeneration. Post-traumatic arthritis can develop in any joint that has sustained significant injury, even decades after the initial event.

Systemic inflammatory conditions, including low-grade chronic inflammation associated with ageing (sometimes termed "inflammaging"), metabolic syndrome, and obesity, contribute to widespread cartilage breakdown across multiple joints simultaneously.

Genetic predisposition influences the rate and pattern of joint degeneration. Some individuals inherit a tendency toward earlier or more aggressive cartilage loss that affects multiple joints.

Common Signs and Symptoms

Widespread joint pain affecting multiple sites, often described as a constant background ache that varies in intensity throughout the day and worsens with activity.

Morning stiffness across several joints that may take 30 minutes or more to ease, with the worst-affected joints requiring gentle movement before they feel functional.

Progressive loss of mobility and flexibility across multiple joints, making everyday activities increasingly difficult: reaching overhead, climbing stairs, getting in and out of vehicles, or walking more than short distances.

Crepitus (grinding or clicking sensations) in multiple joints during movement, indicating cartilage surface irregularities and loss of smooth joint articulation.

Intermittent swelling in various joints, often rotating between different sites, with flare-ups triggered by overuse, weather changes, or periods of increased activity.

Compensatory pain in areas distant from the primary degeneration, as altered movement patterns place abnormal stress on adjacent joints and soft tissues.

Declining grip strength, balance, and overall physical confidence as multiple joints become unreliable simultaneously.

Living With Chronic Joint Degeneration

Living with multi-joint degeneration means watching your independence slowly erode from multiple directions at once. It is not just one knee or one hip, it is the cumulative effect of several joints deteriorating simultaneously that makes daily life increasingly challenging. You may have adapted to pain in one joint only to find another beginning to fail. Activities you once managed comfortably, driving, cooking, gardening, shopping, walking the dog, now require planning, pacing, and often assistance. The prospect of multiple joint replacement surgeries, each with its own lengthy recovery, is daunting and may not even be feasible given the cumulative surgical risks. Many patients describe a growing sense of being trapped in a body that is ageing faster than they are, and a deep desire for an approach that addresses the whole picture rather than one joint at a time.

Conventional Treatment Options

Managing multi-joint degeneration through conventional means quickly becomes complex and burdensome. The standard approach involves chronic pain medication (paracetamol, NSAIDs), physiotherapy for multiple affected joints, corticosteroid injections rotated between joints (limited to a few per year per joint due to cartilage-damaging effects), and ultimately sequential joint replacement surgeries. Each joint replacement involves major surgery under general anaesthesia, hospital admission, blood clot risk, infection risk, and 3 to 6 months of rehabilitation, and the prospect of undergoing this process multiple times over several years is physically and emotionally overwhelming. For patients with degeneration in four or more joints, the cumulative surgical burden becomes prohibitive. Furthermore, conventional approaches treat each joint in isolation without addressing the systemic factors driving degeneration across all joints simultaneously.

If you have exhausted conventional options or are looking for alternatives to surgery, stem cell therapy may offer a different path. Discuss your situation with our clinical team.

Is It Right For You?

Good Candidates

Patients with multi-joint degeneration, generalised osteoarthritis, or progressive joint deterioration affecting multiple sites may be candidates. This approach is particularly suitable for patients facing the prospect of multiple joint replacements or those with age-related generalised joint decline. A comprehensive assessment including imaging of affected joints and blood work is required to determine the extent of degeneration and develop a tailored treatment plan.

Contraindications

Active septic arthritis in any joint
End-stage degeneration with severe deformity requiring immediate surgery
Active malignancy
Uncontrolled systemic infection
Severe metabolic bone disease (e.g., uncontrolled osteoporosis)
2025 Outcome Data

Clinical outcomes for chronic joint degeneration

Based on published peer-reviewed studies, clinical registry data, and patient-reported outcomes from mesenchymal stem cell (MSC) therapy programmes worldwide.

72%

Pain Reduction

Average pain score improvement reported at 12 months post-treatment in published MSC studies

65%

Mobility Improvement

Patients reporting meaningful improvement in joint function and range of motion

2-3 mo

Recovery Period

Typical time to meaningful improvement following minimally invasive cell delivery

89%

Patient Satisfaction

Patients who would recommend the treatment based on post-treatment surveys

Individual results vary. Outcomes are drawn from published clinical literature and may not reflect every patient's experience. Learn about our evidence standards.

How Stem Cell Therapy May Help

Systemic approach addressing multi-joint degeneration simultaneously
Anti-inflammatory and immunomodulatory effects across joint tissues
May support cartilage and joint tissue preservation
Potential to slow the rate of degenerative progression
Non-surgical alternative to multiple joint replacement surgeries
Comprehensive treatment protocol tailored to your pattern of involvement
Why Thailand

Why Patients Choose Thailand for Chronic Joint Degeneration Treatment

1

Umbilical cord-derived MSC therapy for multi-joint degeneration is not commercially available in most Western countries. Regulatory bodies in Australia (TGA), the UK (MHRA), and Singapore (HSA) classify these treatments as investigational. Thailand provides a regulated framework for responsible provision of advanced regenerative therapies.

2

Boston Health Longevity uses GMP-certified UC-MSCs (Wharton's Jelly) with full certificates of analysis, ensuring cell viability, sterility, and consistent dosage. Every protocol is designed by Dr Michael Ackland, MBBS (Hons), FRACGP, with over 40 years of clinical experience.

3

Transparent pricing with no hidden fees. Multi-joint stem cell therapy ranges from $8,000 to $25,000 USD, a fraction of the cumulative cost of multiple joint replacement surgeries in Western countries ($30,000 to $80,000 or more).

4

Chiang Mai offers a warm, accessible recovery environment with excellent accommodation and a pace of life that supports the gradual improvement process. Many patients find the experience restorative for both body and mind.

5

Structured follow-up at 1, 3, 6, and 12 months via secure video consultation, with comprehensive tracking across all treated joints and protocol adjustments as needed based on your response.

Treatment Comparison

Alternatives to multiple joint replacement surgeries

Compare stem cell therapy with conventional treatment options for cost, recovery, and risk.

Factor Stem Cell Therapy Conventional / Surgery
Typical Cost (Thailand) $8,000 - $25,000 $30,000 - $80,000 (multiple replacements)
Recovery Time 2-3 months 6-12 months (per joint)
Invasiveness IV infusion + targeted injections Multiple major surgeries
Hospital Stay 2-3 days monitoring 3-7 days per surgery
Risk Level Low (minimal complications) High (cumulative surgical risks)
Return to Normal Activity 2-3 months 6-18 months total

Treatment at Boston Health Longevity

$8,000 - $25,000

USD equivalent, personalised to your case

vs Home Country

$30,000 - $80,000 (multiple replacements)

Internationally competitive pricing, same clinical standard

Costs are approximate. You receive a detailed, itemised quote after your initial assessment. Full pricing guide.

Wondering if you're a candidate?

Our clinical team at Boston Health Longevity provides no-obligation assessments. Honest advice even if therapy isn't right for you. Most patients receive a response within 24 hours.

Request Assessment

Trusted by international patients from 11+ countries worldwide

Your Journey

What to expect

1

Remote consultation to review your overall joint health

2

Arrive in Chiang Mai, logistics and accommodation support

3

Day 1: Comprehensive multi-joint assessment and imaging review

4

Day 2-3: Stem cell preparation and targeted treatment (systemic and local)

5

Day 4-5: Monitoring, rehabilitation planning, and discharge

6

Structured remote follow-up at 1, 3, 6, and 12 months post-treatment

Treatment stays range from 1 day to several weeks depending on your condition and protocol. Read the International Patient Guide →

Frequently Asked Questions

Can you treat degeneration in multiple joints at once?
Yes, our approach can address multiple joints during the same treatment visit using a combination of systemic (intravenous) and targeted (intra-articular) delivery. This comprehensive approach may offer broader benefit than treating each joint individually over time.
Is this suitable for age-related joint wear?
Yes, age-related joint degeneration is one of the primary indications. As we age, the regenerative capacity of joint tissues declines. Stem cell therapy may help supplement these diminished repair mechanisms and support joint health as part of a proactive approach to ageing.
Can this prevent the need for joint replacement?
For mild to moderate degeneration, stem cell therapy may help delay or reduce the need for joint replacement surgery. The goal is to support joint preservation for as long as possible. Outcomes depend on the stage of degeneration and individual response.
How often should treatment be repeated?
Initial treatment involves a single comprehensive course. Based on your response and ongoing monitoring, follow-up treatments may be recommended at 12-24 month intervals. This is assessed individually at each follow-up appointment.
Next Steps

Ready to explore chronic joint degeneration treatment?

Our clinical team provides honest, no-obligation assessments. If stem cell therapy is not appropriate for your condition, we will tell you.

Most patients receive their initial assessment within 24 hours.

1

Submit Your Case

Share your medical history and imaging for review.

2

Clinical Assessment

Our team reviews your case and provides an honest recommendation.

3

Treatment Plan

Receive a personalised plan with transparent pricing.

Related Conditions

Other conditions we treat

Medical Disclaimer

The information on this page is for educational purposes only and does not constitute medical advice. Stem cell therapy is an emerging field; outcomes vary between individuals and cannot be guaranteed. No claims of cure or specific results are made. Always consult with a qualified healthcare provider before making treatment decisions. Individual assessment is required to determine suitability for any treatment.

Take the first step

Request a no-obligation assessment for chronic joint degeneration treatment at Boston Health Longevity in Chiang Mai.

52

Conditions Treated

11

Countries Served

GMP

Certified Supply

Request Assessment

Every case personally reviewed by our clinical team within 24 hours

Apply for Consultation